Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Exp Gerontol. 2021 Jun 16;152:111454. doi: 10.1016/j.exger.2021.111454

Table 2.

Clinical characteristics of breast cancer survivors (BCS).

BCS (n=13)
Time from last treatment (d) 82 (90)
Time from surgery (d) 224 (115)
Time from radiation (d) 62 (78)
Time from chemotherapy (d) 152 (100)
Stage
   I (%) 5 (38)
   II (%) 6 (46)
   III (%) 2 (15)
Tumor Status
 ER+ Positive (%) 12 (92)
 PR+ Positive (%) 12 (92)
 HER2+ Positive (%) 4 (31)
 ER−/PR−/HER2− (%) 1 (8)
Pre-Menopausal (%) 5 (38)
Post-Menopausal (%) 8 (62)

Data are mean (SD) or (%). Abbreviations: BCS, Breast Cancer Survivor; ER, Estrogen-Receptor; PR, Progesterone-Receptor; HER2, Human Epidermal Growth Factor Receptor 2.